Reuters -- Galapagos and GlaxoSmithKline today announced they have reached an agreement for
Galapagos to acquire GSK's state-of-the art research centre in Zagreb, Croatia. The
arrangement, which is subject to closing conditions and is expected to be effective as
of 9 September 2010, provides for ongoing employment of the staff at the centre and will
provide additional capacity for Galapagos' growing R&D requirements.
